Custom Health Holdings Inc. has seen notable price movements this week, buoyed by strategic acquisitions and favorable analyst ratings.
Custom Health Holdings Inc. (CHLT.TO) has experienced a robust week in the market, with its stock price rising by 9.40% over the last five trading days. This upward trend can be attributed to recent company news and positive analyst sentiment.
Investor takeaway: Investors should consider the implications of Custom Health's recent acquisitions and analyst ratings while also being mindful of the company's current financial challenges.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Custom Health Holdings Inc.
CHLT.TO
CHLT.TO
Custom Health Holdings Inc.
WealthAwesomeMarket cap
$183.53M
52W high
$11.00
52W low
$5.25
Analyst Price Targets
Based on analyst covering CHLT
Wall Street analysts forecast CHLT stock price to rise 69.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.00
+69.0% Upside
Current Price
C$7.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Custom Health's stock up 9.40% this week amid acquisitions.
The stock's current price of C$6.90 is significantly below its 52-week high of C$11.00, indicating potential for recovery but also highlighting past volatility.
Bull case
The acquisition of Evergreen Pharmacy positions Custom Health to expand its market presence and potentially improve its financial metrics. This move could attract further investment interest as the company enhances its operational capabilities.
Bear case
Despite the positive news, Custom Health's significant losses and negative profit margin present risks that could affect its long-term viability and stock performance.
Recent Price Action
Custom Health Holdings Inc. (CHLT.TO) closed at C$6.90 on the latest trading day, reflecting a daily increase of 1.28%. Over the past week, the stock has gained 9.40%, driven by positive developments within the company.
Company News and Catalysts
This week, Custom Health made headlines with the announcement of its acquisition of Evergreen Pharmacy for US$3.5 million. This strategic move is expected to enhance the company's operational capabilities and market reach. Additionally, Stifel has recently assigned a Buy rating to Custom Health, further boosting investor confidence.
Technical Picture
From a technical standpoint, Custom Health's stock is currently trading near its 50-day and 200-day moving averages, both at C$6.97, indicating a slight underperformance of 1.0%. The stock has a 52-week trading range of C$5.25 to C$11.00, with the current price at approximately 29% of this range. The recent trading volume of 16,551 shares is slightly above the 20-day average volume of 24,428 shares, suggesting increased investor interest.
Insider Activity
No recent insider trading activity has been reported for Custom Health Holdings Inc., which can indicate a stable management outlook at this time.
Price Action Summary
Custom Health Holdings Inc. closed at C$6.90, marking a 1D increase of 1.28%. Investors should remain cautious, considering the company's current financial challenges despite recent positive developments.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
